AbbVie Needs More to Land Shire – Wall Street Journal

Wall Street Journal
This has rapidly become a familiar tale: A U.S. health-care company approaches a European target with a generously pitched, strategically questionable takeover proposal that would involve flipping into a lower tax jurisdiction. But AbbVie ABBV +0.18% …
UPDATE 3-Shire rejects AbbVie’s $46 billion takeover bidReuters
Shire rejects AbbVie’s $46 billion takeover bidFox Business
Drug Maker Shire Rejects Offer From AbbVie Worth About $46 BillionNew York Times
BloombergUSA TODAYTelegraph.co.uk
all 238 news articles

…read more

Source: Business News From Google News

Leave a Comment